Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Market
Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Market

Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Comprehensive Study by Type (Acute Emesis, Delayed Emesis, Anticipatory Emesis, Refractory Emesis), Drug Type (Branded, Generics), Therapy (Nk-1 Receptor Antagonist, Serotonin Receptor Antagonist, Others), Population Type (Children’s, Adults), End-User (Hospitals,, Specialty Clinics, Home Healthcare, Others), Distribution channel (Retail Pharmacy, Online Pharmacies, Others) Players and Region - Global Market Outlook to 2027

Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Apr 2022 Edition 236 Pages 219 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Market Scope
Chemotherapy-induced nausea and vomiting (CINV) is the term for nausea and vomiting (emesis) produced by cancer medications (CINV). Patients may have nausea and vomiting within 24 hours of starting chemotherapy (acute) or after 24 hours of starting chemotherapy (delayed). Chemotherapy-induced nausea and vomiting cause cancer patients to postpone or refuse chemotherapy treatment. The market will grow due to an increase in the number of patients having chemotherapy, increased compliance with chemotherapy medications, and the introduction of very promising novel drugs. The development of a company's product portfolio market, as well as new advancements in delivery type, will also heighten various opportunities that will begin to germinate in chemotherapy-induced nausea and vomiting medications market throughout the projected period.

The Chemotherapy-Induced Nausea Vomiting (CINV) Drugs market study is segmented by Type (Acute Emesis, Delayed Emesis, Anticipatory Emesis and Refractory Emesis) and major geographies with country level break-up.

Mergers and acquisitions, expansions, investments, new service launches, and collaborations are some of the companies' preferred market-exploration strategies. To Competitive advantage through synergy, players are growing and acquiring businesses in new geographies. The company is contributing its share to growing the market. There are several significant participants in the CINV Drug industry, which is moderately competitive. Merck & Co., Inc., GlaxoSmithKline plc, Heron Therapeutics, Inc., Helsinn Holding S.A., Baxter Healthcare, Sandoz (Novartis AG), Orchid Healthcare, Mylan Pharmaceuticals, Inc., Teva Pharmaceuticals, and Sun Pharma are some of the market leaders.

Helsinn Holding S.A. (Switzerland), Tesaro, Inc (United States), Kyowa Kirin, Inc. (India), Pfizer Inc. (United States), GlaxoSmithKline plc. (United Kingdom), AbbVie Inc. (United States), Merck & Co., Inc. (United States), Bausch Health Companies Inc. (Canada), Novartis AG (Switzerland) and Ono Pharmaceutical Co., Ltd. (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Camurus AB (Sweden) and Heron Therapeutics, Inc. (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AMA Research has segmented the market of Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs market by Type, Application and Region.

On the basis of geography, the market of Chemotherapy-Induced Nausea Vomiting (CINV) Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In Jan 2020, Pfizer Inc. has bought Array BioPharma Inc., a pharmaceutical business based in the United States. This acquisition is expected to boost the company's creative biopharmaceutical business and help satisfy unmet medical requirements for diseases including cancer and other rare diseases.


Market Drivers
  • Online Pharmacies' Easy Availability of Chemotherapy-Induced Nausea and Vomiting Treatment Medications Will Improve Sales
  • Accelerated Drug Approvals Will Boost Sales of Chemotherapy-Induced Nausea and Vomiting Therapies

Opportunities
  • Advanced Technology Developments to Discover New High Potential Drugs Create an Opportunity
  • Increasing Drug Manufactures and Increase Funding to Prevent Cancer Cases

Restraints
  • Regulations Governing CINV Medications' Access and Availability May Hinder Market Growth
  • High Price of CINV Drugs

Challenges
  • High Competition in the Market


Key Target Audience
Industry Association, Downstream Vendors, Marketing & Consulting firms, Venture Capitalists, Government & Regulatory Bodies and Investors

Frequently Asked Questions (FAQ):

1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.

2. How big is the Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2027.

Report Objectives / Segmentation Covered
By Type
  • Acute Emesis
  • Delayed Emesis
  • Anticipatory Emesis
  • Refractory Emesis
By Drug Type
  • Branded
  • Generics

By Therapy
  • Nk-1 Receptor Antagonist
  • Serotonin Receptor Antagonist
  • Others

By Population Type
  • Children’s
  • Adults

By End-User
  • Hospitals,
  • Specialty Clinics
  • Home Healthcare
  • Others

By Distribution channel
  • Retail Pharmacy
  • Online Pharmacies
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Online Pharmacies' Easy Availability of Chemotherapy-Induced Nausea and Vomiting Treatment Medications Will Improve Sales
      • 3.2.2. Accelerated Drug Approvals Will Boost Sales of Chemotherapy-Induced Nausea and Vomiting Therapies
    • 3.3. Market Challenges
      • 3.3.1. High Competition in the Market
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type, Drug Type, Therapy, Population Type, End-User, Distribution channel and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs (Value)
      • 5.2.1. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs by: Type (Value)
        • 5.2.1.1. Acute Emesis
        • 5.2.1.2. Delayed Emesis
        • 5.2.1.3. Anticipatory Emesis
        • 5.2.1.4. Refractory Emesis
      • 5.2.2. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs by: Drug Type (Value)
        • 5.2.2.1. Branded
        • 5.2.2.2. Generics
      • 5.2.3. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs by: Therapy (Value)
        • 5.2.3.1. Nk-1 Receptor Antagonist
        • 5.2.3.2. Serotonin Receptor Antagonist
        • 5.2.3.3. Others
      • 5.2.4. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs by: Population Type (Value)
        • 5.2.4.1. Children’s
        • 5.2.4.2. Adults
      • 5.2.5. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs by: End-User (Value)
        • 5.2.5.1. Hospitals,
        • 5.2.5.2. Specialty Clinics
        • 5.2.5.3. Home Healthcare
        • 5.2.5.4. Others
      • 5.2.6. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs by: Distribution channel (Value)
        • 5.2.6.1. Retail Pharmacy
        • 5.2.6.2. Online Pharmacies
        • 5.2.6.3. Others
      • 5.2.7. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Region
        • 5.2.7.1. South America
          • 5.2.7.1.1. Brazil
          • 5.2.7.1.2. Argentina
          • 5.2.7.1.3. Rest of South America
        • 5.2.7.2. Asia Pacific
          • 5.2.7.2.1. China
          • 5.2.7.2.2. Japan
          • 5.2.7.2.3. India
          • 5.2.7.2.4. South Korea
          • 5.2.7.2.5. Australia
          • 5.2.7.2.6. Rest of Asia-Pacific
        • 5.2.7.3. Europe
          • 5.2.7.3.1. Germany
          • 5.2.7.3.2. France
          • 5.2.7.3.3. Italy
          • 5.2.7.3.4. United Kingdom
          • 5.2.7.3.5. Netherlands
          • 5.2.7.3.6. Rest of Europe
        • 5.2.7.4. MEA
          • 5.2.7.4.1. Middle East
          • 5.2.7.4.2. Africa
        • 5.2.7.5. North America
          • 5.2.7.5.1. United States
          • 5.2.7.5.2. Canada
          • 5.2.7.5.3. Mexico
    • 5.3. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs (Price)
      • 5.3.1. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs by: Type (Price)
  • 6. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Helsinn Holding S.A. (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Tesaro, Inc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Kyowa Kirin, Inc. (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GlaxoSmithKline plc. (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. AbbVie Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Merck & Co., Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bausch Health Companies Inc. (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Novartis AG (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Ono Pharmaceutical Co., Ltd. (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Sale, by Type, Drug Type, Therapy, Population Type, End-User, Distribution channel and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs (Value)
      • 7.2.1. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs by: Type (Value)
        • 7.2.1.1. Acute Emesis
        • 7.2.1.2. Delayed Emesis
        • 7.2.1.3. Anticipatory Emesis
        • 7.2.1.4. Refractory Emesis
      • 7.2.2. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs by: Drug Type (Value)
        • 7.2.2.1. Branded
        • 7.2.2.2. Generics
      • 7.2.3. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs by: Therapy (Value)
        • 7.2.3.1. Nk-1 Receptor Antagonist
        • 7.2.3.2. Serotonin Receptor Antagonist
        • 7.2.3.3. Others
      • 7.2.4. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs by: Population Type (Value)
        • 7.2.4.1. Children’s
        • 7.2.4.2. Adults
      • 7.2.5. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs by: End-User (Value)
        • 7.2.5.1. Hospitals,
        • 7.2.5.2. Specialty Clinics
        • 7.2.5.3. Home Healthcare
        • 7.2.5.4. Others
      • 7.2.6. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs by: Distribution channel (Value)
        • 7.2.6.1. Retail Pharmacy
        • 7.2.6.2. Online Pharmacies
        • 7.2.6.3. Others
      • 7.2.7. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Region
        • 7.2.7.1. South America
          • 7.2.7.1.1. Brazil
          • 7.2.7.1.2. Argentina
          • 7.2.7.1.3. Rest of South America
        • 7.2.7.2. Asia Pacific
          • 7.2.7.2.1. China
          • 7.2.7.2.2. Japan
          • 7.2.7.2.3. India
          • 7.2.7.2.4. South Korea
          • 7.2.7.2.5. Australia
          • 7.2.7.2.6. Rest of Asia-Pacific
        • 7.2.7.3. Europe
          • 7.2.7.3.1. Germany
          • 7.2.7.3.2. France
          • 7.2.7.3.3. Italy
          • 7.2.7.3.4. United Kingdom
          • 7.2.7.3.5. Netherlands
          • 7.2.7.3.6. Rest of Europe
        • 7.2.7.4. MEA
          • 7.2.7.4.1. Middle East
          • 7.2.7.4.2. Africa
        • 7.2.7.5. North America
          • 7.2.7.5.1. United States
          • 7.2.7.5.2. Canada
          • 7.2.7.5.3. Mexico
    • 7.3. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs (Price)
      • 7.3.1. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Type(USD Million)
  • Table 2. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Acute Emesis , by Region USD Million (2016-2021)
  • Table 3. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Delayed Emesis , by Region USD Million (2016-2021)
  • Table 4. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Anticipatory Emesis , by Region USD Million (2016-2021)
  • Table 5. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Refractory Emesis , by Region USD Million (2016-2021)
  • Table 6. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Drug Type(USD Million)
  • Table 7. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Branded , by Region USD Million (2016-2021)
  • Table 8. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Generics , by Region USD Million (2016-2021)
  • Table 9. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Therapy(USD Million)
  • Table 10. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Nk-1 Receptor Antagonist , by Region USD Million (2016-2021)
  • Table 11. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Serotonin Receptor Antagonist , by Region USD Million (2016-2021)
  • Table 12. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Others , by Region USD Million (2016-2021)
  • Table 13. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Population Type(USD Million)
  • Table 14. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Children’s , by Region USD Million (2016-2021)
  • Table 15. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Adults , by Region USD Million (2016-2021)
  • Table 16. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by End-User(USD Million)
  • Table 17. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Hospitals, , by Region USD Million (2016-2021)
  • Table 18. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Specialty Clinics , by Region USD Million (2016-2021)
  • Table 19. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Home Healthcare , by Region USD Million (2016-2021)
  • Table 20. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Others , by Region USD Million (2016-2021)
  • Table 21. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Distribution channel(USD Million)
  • Table 22. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Retail Pharmacy , by Region USD Million (2016-2021)
  • Table 23. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Online Pharmacies , by Region USD Million (2016-2021)
  • Table 24. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Others , by Region USD Million (2016-2021)
  • Table 25. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Country USD Million (2016-2021)
  • Table 26. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 27. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 28. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 29. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 30. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 31. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 32. Brazil Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 33. Brazil Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 34. Brazil Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 35. Brazil Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 36. Brazil Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 37. Brazil Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 38. Argentina Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 39. Argentina Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 40. Argentina Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 41. Argentina Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 42. Argentina Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 43. Argentina Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 44. Rest of South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 45. Rest of South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 46. Rest of South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 47. Rest of South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 48. Rest of South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 49. Rest of South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 50. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Country USD Million (2016-2021)
  • Table 51. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 52. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 53. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 54. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 55. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 56. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 57. China Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 58. China Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 59. China Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 60. China Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 61. China Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 62. China Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 63. Japan Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 64. Japan Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 65. Japan Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 66. Japan Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 67. Japan Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 68. Japan Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 69. India Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 70. India Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 71. India Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 72. India Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 73. India Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 74. India Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 75. South Korea Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 76. South Korea Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 77. South Korea Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 78. South Korea Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 79. South Korea Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 80. South Korea Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 81. Australia Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 82. Australia Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 83. Australia Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 84. Australia Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 85. Australia Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 86. Australia Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 87. Rest of Asia-Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 88. Rest of Asia-Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 89. Rest of Asia-Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 90. Rest of Asia-Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 91. Rest of Asia-Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 92. Rest of Asia-Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 93. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Country USD Million (2016-2021)
  • Table 94. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 95. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 96. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 97. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 98. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 99. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 100. Germany Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 101. Germany Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 102. Germany Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 103. Germany Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 104. Germany Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 105. Germany Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 106. France Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 107. France Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 108. France Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 109. France Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 110. France Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 111. France Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 112. Italy Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 113. Italy Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 114. Italy Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 115. Italy Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 116. Italy Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 117. Italy Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 118. United Kingdom Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 119. United Kingdom Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 120. United Kingdom Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 121. United Kingdom Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 122. United Kingdom Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 123. United Kingdom Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 124. Netherlands Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 125. Netherlands Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 126. Netherlands Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 127. Netherlands Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 128. Netherlands Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 129. Netherlands Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 130. Rest of Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 131. Rest of Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 132. Rest of Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 133. Rest of Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 134. Rest of Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 135. Rest of Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 136. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Country USD Million (2016-2021)
  • Table 137. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 138. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 139. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 140. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 141. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 142. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 143. Middle East Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 144. Middle East Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 145. Middle East Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 146. Middle East Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 147. Middle East Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 148. Middle East Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 149. Africa Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 150. Africa Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 151. Africa Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 152. Africa Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 153. Africa Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 154. Africa Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 155. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Country USD Million (2016-2021)
  • Table 156. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 157. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 158. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 159. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 160. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 161. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 162. United States Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 163. United States Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 164. United States Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 165. United States Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 166. United States Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 167. United States Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 168. Canada Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 169. Canada Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 170. Canada Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 171. Canada Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 172. Canada Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 173. Canada Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 174. Mexico Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2016-2021)
  • Table 175. Mexico Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2016-2021)
  • Table 176. Mexico Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2016-2021)
  • Table 177. Mexico Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2016-2021)
  • Table 178. Mexico Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2016-2021)
  • Table 179. Mexico Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2016-2021)
  • Table 180. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Type(USD/Units)
  • Table 181. Company Basic Information, Sales Area and Its Competitors
  • Table 182. Company Basic Information, Sales Area and Its Competitors
  • Table 183. Company Basic Information, Sales Area and Its Competitors
  • Table 184. Company Basic Information, Sales Area and Its Competitors
  • Table 185. Company Basic Information, Sales Area and Its Competitors
  • Table 186. Company Basic Information, Sales Area and Its Competitors
  • Table 187. Company Basic Information, Sales Area and Its Competitors
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Type(USD Million)
  • Table 192. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Acute Emesis , by Region USD Million (2022-2027)
  • Table 193. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Delayed Emesis , by Region USD Million (2022-2027)
  • Table 194. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Anticipatory Emesis , by Region USD Million (2022-2027)
  • Table 195. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Refractory Emesis , by Region USD Million (2022-2027)
  • Table 196. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Drug Type(USD Million)
  • Table 197. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Branded , by Region USD Million (2022-2027)
  • Table 198. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Generics , by Region USD Million (2022-2027)
  • Table 199. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Therapy(USD Million)
  • Table 200. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Nk-1 Receptor Antagonist , by Region USD Million (2022-2027)
  • Table 201. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Serotonin Receptor Antagonist , by Region USD Million (2022-2027)
  • Table 202. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Others , by Region USD Million (2022-2027)
  • Table 203. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Population Type(USD Million)
  • Table 204. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Children’s , by Region USD Million (2022-2027)
  • Table 205. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Adults , by Region USD Million (2022-2027)
  • Table 206. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by End-User(USD Million)
  • Table 207. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Hospitals, , by Region USD Million (2022-2027)
  • Table 208. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Specialty Clinics , by Region USD Million (2022-2027)
  • Table 209. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Home Healthcare , by Region USD Million (2022-2027)
  • Table 210. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Others , by Region USD Million (2022-2027)
  • Table 211. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Distribution channel(USD Million)
  • Table 212. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Retail Pharmacy , by Region USD Million (2022-2027)
  • Table 213. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Online Pharmacies , by Region USD Million (2022-2027)
  • Table 214. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Others , by Region USD Million (2022-2027)
  • Table 215. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Country USD Million (2022-2027)
  • Table 216. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 217. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 218. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 219. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 220. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 221. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 222. Brazil Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 223. Brazil Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 224. Brazil Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 225. Brazil Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 226. Brazil Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 227. Brazil Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 228. Argentina Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 229. Argentina Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 230. Argentina Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 231. Argentina Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 232. Argentina Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 233. Argentina Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 234. Rest of South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 235. Rest of South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 236. Rest of South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 237. Rest of South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 238. Rest of South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 239. Rest of South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 240. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Country USD Million (2022-2027)
  • Table 241. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 242. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 243. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 244. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 245. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 246. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 247. China Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 248. China Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 249. China Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 250. China Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 251. China Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 252. China Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 253. Japan Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 254. Japan Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 255. Japan Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 256. Japan Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 257. Japan Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 258. Japan Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 259. India Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 260. India Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 261. India Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 262. India Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 263. India Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 264. India Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 265. South Korea Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 266. South Korea Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 267. South Korea Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 268. South Korea Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 269. South Korea Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 270. South Korea Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 271. Australia Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 272. Australia Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 273. Australia Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 274. Australia Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 275. Australia Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 276. Australia Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 277. Rest of Asia-Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 278. Rest of Asia-Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 279. Rest of Asia-Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 280. Rest of Asia-Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 281. Rest of Asia-Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 282. Rest of Asia-Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 283. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Country USD Million (2022-2027)
  • Table 284. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 285. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 286. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 287. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 288. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 289. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 290. Germany Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 291. Germany Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 292. Germany Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 293. Germany Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 294. Germany Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 295. Germany Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 296. France Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 297. France Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 298. France Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 299. France Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 300. France Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 301. France Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 302. Italy Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 303. Italy Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 304. Italy Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 305. Italy Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 306. Italy Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 307. Italy Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 308. United Kingdom Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 309. United Kingdom Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 310. United Kingdom Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 311. United Kingdom Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 312. United Kingdom Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 313. United Kingdom Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 314. Netherlands Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 315. Netherlands Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 316. Netherlands Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 317. Netherlands Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 318. Netherlands Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 319. Netherlands Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 320. Rest of Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 321. Rest of Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 322. Rest of Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 323. Rest of Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 324. Rest of Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 325. Rest of Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 326. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Country USD Million (2022-2027)
  • Table 327. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 328. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 329. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 330. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 331. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 332. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 333. Middle East Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 334. Middle East Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 335. Middle East Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 336. Middle East Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 337. Middle East Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 338. Middle East Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 339. Africa Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 340. Africa Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 341. Africa Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 342. Africa Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 343. Africa Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 344. Africa Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 345. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Country USD Million (2022-2027)
  • Table 346. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 347. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 348. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 349. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 350. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 351. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 352. United States Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 353. United States Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 354. United States Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 355. United States Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 356. United States Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 357. United States Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 358. Canada Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 359. Canada Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 360. Canada Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 361. Canada Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 362. Canada Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 363. Canada Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 364. Mexico Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Type USD Million (2022-2027)
  • Table 365. Mexico Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Drug Type USD Million (2022-2027)
  • Table 366. Mexico Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Therapy USD Million (2022-2027)
  • Table 367. Mexico Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Population Type USD Million (2022-2027)
  • Table 368. Mexico Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by End-User USD Million (2022-2027)
  • Table 369. Mexico Chemotherapy-Induced Nausea Vomiting (CINV) Drugs, by Distribution channel USD Million (2022-2027)
  • Table 370. Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Type(USD/Units)
  • Table 371. Research Programs/Design for This Report
  • Table 372. Key Data Information from Secondary Sources
  • Table 373. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Type USD Million (2016-2021)
  • Figure 5. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Drug Type USD Million (2016-2021)
  • Figure 6. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Therapy USD Million (2016-2021)
  • Figure 7. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Population Type USD Million (2016-2021)
  • Figure 8. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by End-User USD Million (2016-2021)
  • Figure 9. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Distribution channel USD Million (2016-2021)
  • Figure 10. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Share (%), by Country
  • Figure 11. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Share (%), by Country
  • Figure 12. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Share (%), by Country
  • Figure 13. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Share (%), by Country
  • Figure 14. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Share (%), by Country
  • Figure 15. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Type USD/Units (2016-2021)
  • Figure 16. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs share by Players 2021 (%)
  • Figure 17. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs share by Players (Top 3) 2021(%)
  • Figure 18. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs share by Players (Top 5) 2021(%)
  • Figure 19. BCG Matrix for key Companies
  • Figure 20. Helsinn Holding S.A. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 21. Helsinn Holding S.A. (Switzerland) Revenue: by Geography 2021
  • Figure 22. Tesaro, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 23. Tesaro, Inc (United States) Revenue: by Geography 2021
  • Figure 24. Kyowa Kirin, Inc. (India) Revenue, Net Income and Gross profit
  • Figure 25. Kyowa Kirin, Inc. (India) Revenue: by Geography 2021
  • Figure 26. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Pfizer Inc. (United States) Revenue: by Geography 2021
  • Figure 28. GlaxoSmithKline plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. GlaxoSmithKline plc. (United Kingdom) Revenue: by Geography 2021
  • Figure 30. AbbVie Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. AbbVie Inc. (United States) Revenue: by Geography 2021
  • Figure 32. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Merck & Co., Inc. (United States) Revenue: by Geography 2021
  • Figure 34. Bausch Health Companies Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 35. Bausch Health Companies Inc. (Canada) Revenue: by Geography 2021
  • Figure 36. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 37. Novartis AG (Switzerland) Revenue: by Geography 2021
  • Figure 38. Ono Pharmaceutical Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 39. Ono Pharmaceutical Co., Ltd. (Japan) Revenue: by Geography 2021
  • Figure 40. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Type USD Million (2022-2027)
  • Figure 41. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Drug Type USD Million (2022-2027)
  • Figure 42. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Therapy USD Million (2022-2027)
  • Figure 43. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Population Type USD Million (2022-2027)
  • Figure 44. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by End-User USD Million (2022-2027)
  • Figure 45. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Distribution channel USD Million (2022-2027)
  • Figure 46. South America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Share (%), by Country
  • Figure 47. Asia Pacific Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Share (%), by Country
  • Figure 48. Europe Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Share (%), by Country
  • Figure 49. MEA Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Share (%), by Country
  • Figure 50. North America Chemotherapy-Induced Nausea Vomiting (CINV) Drugs Share (%), by Country
  • Figure 51. Global Chemotherapy-Induced Nausea Vomiting (CINV) Drugs: by Type USD/Units (2022-2027)
Some of the key companies/manufacturers profiled in the report
  • Helsinn Holding S.A. (Switzerland)
  • Tesaro, Inc (United States)
  • Kyowa Kirin, Inc. (India)
  • Pfizer Inc. (United States)
  • GlaxoSmithKline plc. (United Kingdom)
  • AbbVie Inc. (United States)
  • Merck & Co., Inc. (United States)
  • Bausch Health Companies Inc. (Canada)
  • Novartis AG (Switzerland)
  • Ono Pharmaceutical Co., Ltd. (Japan)
Additional players considered in the study are as follows:
Camurus AB (Sweden) , Heron Therapeutics, Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation